N(2)-(2-carboxyethyl)arginine synthase

BE0003275ProteinStreptomyces clavuligerusceaS

Involved in the biosynthesis of the beta-lactamase inhibitor, clavulanic acid. It is acted on by 1 drug in DrugBank.

Gene name
ceaS
UniProtKB entry
Q9LCV9Swiss-Prot
Residues / weight
573 residues · 60,907 Da
Also known as
2.5.1.66 · CEA synthetase

Resolves to

Protein
UniProtQ9LCV9UniProt nameCEAS_STRCL
Structure
PDB1UPAPDB1UPBPDB1UPC
Drugs

What you can answer from here — as of September 04, 2024

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
3GO termsFunction, process and component, as structured annotations
Sign in
3Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on N(2)-(2-carboxyethyl)arginine synthase, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In